OTTAWA--An advance estimate of Canadian wholesale trade indicates sales pulled back in March on the back of broad weakness. Statistics Canada on Monday said an advance tally of wholesale sales points ...

Niles reckons that finding the market bottom will normally take more time unless there is fiscal stimulus or easier monetary policy. However, the government is currently prioritizing spending cuts and ...

--Erste Group Bank is considering buying a 49% stake owned by Spanish lender Santander in its Polish division, which could trigger a mandatory takeover offer for Santander Bank Polska, Bloomberg ...

Domino's (DPZ) U.S. same-store sales, or sales in stores open at least a year, declined 0.5%, compared with a jump of 5.6% in the year-ago quarter, adjusted for currency. International same-store ...

The solid cash conversion allows Telix to internally fund organic growth and flexibility to pursue acquisitions. We expect the company to reinvest the majority of earnings into R&D. We forecast ...

In addition, MPACT is exposed to foreign currency risk as about half of its assets under management are outside of Singapore. This is managed by using foreign currency-denominated borrowings as a ...

Barrick Gold is dropping the gold from its name, a nod to the increasing importance of copper in its portfolio of operations. The Canadian mining company said it plans to change its name to Barrick ...

A massive power outage struck the Iberian Peninsula on Monday, affecting millions across Spain and Portugal and causing widespread disruption to essential services.

Slashes Spending as Tariff Uncertainty Swirls CEOs are pausing travel, delaying construction projects and slowing hiring in response to tariffs and cloudy economic forecasts: "Control the ...

South Africa, Japan and Saudi Arabia are among the nations that have sought counsel from the Wall Street giant. The lender's a bid for the private bank is the latest twist in a wave of consolidation ...

Germany's Merck KGaA agreed to acquire U.S. biopharmaceutical company SpringWorks Therapeutics for around $3.9 billion, in a bid to expand its oncology and rare disease business.